Monte Rosa Therapeutics Q1 2025 Earnings Report

Expected Revenue:$13.6M
+869.3% YoY
Expected EPS:-$0.32
+42.9% YoY

Monte Rosa Therapeutics

Monte Rosa Therapeutics